Electro Medical Services (Basingstoke) Limited 07617420 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is the sale and service of medical equipment Digita Accounts Production Advanced 6.30.9574.0 true true 07617420 2023-04-01 2024-03-31 07617420 2024-03-31 07617420 bus:OrdinaryShareClass1 2024-03-31 07617420 core:CurrentFinancialInstruments 2024-03-31 07617420 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 07617420 core:LandBuildings core:OwnedOrFreeholdAssets 2024-03-31 07617420 core:OfficeEquipment 2024-03-31 07617420 core:PlantMachinery 2024-03-31 07617420 bus:SmallEntities 2023-04-01 2024-03-31 07617420 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 07617420 bus:FilletedAccounts 2023-04-01 2024-03-31 07617420 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 07617420 bus:RegisteredOffice 2023-04-01 2024-03-31 07617420 bus:Director1 2023-04-01 2024-03-31 07617420 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 07617420 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 07617420 core:Buildings 2023-04-01 2024-03-31 07617420 core:ComputerEquipment 2023-04-01 2024-03-31 07617420 core:LandBuildings core:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 07617420 core:OfficeEquipment 2023-04-01 2024-03-31 07617420 core:PlantMachinery 2023-04-01 2024-03-31 07617420 countries:EnglandWales 2023-04-01 2024-03-31 07617420 2023-03-31 07617420 core:LandBuildings core:OwnedOrFreeholdAssets 2023-03-31 07617420 core:OfficeEquipment 2023-03-31 07617420 core:PlantMachinery 2023-03-31 07617420 2022-04-01 2023-03-31 07617420 2023-03-31 07617420 bus:OrdinaryShareClass1 2023-03-31 07617420 core:CurrentFinancialInstruments 2023-03-31 07617420 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 07617420 core:LandBuildings core:OwnedOrFreeholdAssets 2023-03-31 07617420 core:OfficeEquipment 2023-03-31 07617420 core:PlantMachinery 2023-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 07617420

Electro Medical Services (Basingstoke) Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2024

 

Electro Medical Services (Basingstoke) Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 8

 

Electro Medical Services (Basingstoke) Limited

Company Information

Director

Mr Antony Clarke

Registered office

35 Wellington Road
Andover
SP10 3JW

Accountants

Deborah Rees ACMA
AIMS Accountants for Business
5 Benedict Close
Romsey
Hampshire
SO51 8PN

 

Electro Medical Services (Basingstoke) Limited

(Registration number: 07617420)
Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

-

4,142

Current assets

 

Stocks

5

-

930

Debtors

6

335

(102)

Cash at bank and in hand

 

251

394

 

586

1,222

Creditors: Amounts falling due within one year

7

(2,438)

(2,685)

Net current liabilities

 

(1,852)

(1,463)

Total assets less current liabilities

 

(1,852)

2,679

Provisions for liabilities

-

(374)

Net (liabilities)/assets

 

(1,852)

2,305

Capital and reserves

 

Called up share capital

8

500

500

Retained earnings

(2,352)

1,805

Shareholders' (deficit)/funds

 

(1,852)

2,305

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

 

Electro Medical Services (Basingstoke) Limited

(Registration number: 07617420)
Balance Sheet as at 31 March 2024

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 4 December 2024
 

.........................................
Mr Antony Clarke
Director

   
     
 

Electro Medical Services (Basingstoke) Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
35 Wellington Road
Andover
SP10 3JW

These financial statements were authorised for issue by the director on 4 December 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on the basis the company ceased trading on 31 March 2024.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

 

Electro Medical Services (Basingstoke) Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Improvements to property

10% on cost

Plant and machinery

25% on reducing balance

Computer equipment

33% on cost

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Electro Medical Services (Basingstoke) Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 1).

 

Electro Medical Services (Basingstoke) Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

4

Tangible assets

Improvements to property
£

Plant and machinery
£

Computer equipment
£

Total
£

Cost or valuation

At 1 April 2023

7,582

4,000

1,954

13,536

Disposals

(7,582)

(4,000)

(1,954)

(13,536)

At 31 March 2024

-

-

-

-

Depreciation

At 1 April 2023

4,554

3,873

967

9,394

Eliminated on disposal

(4,554)

(3,873)

(967)

(9,394)

At 31 March 2024

-

-

-

-

Carrying amount

At 31 March 2024

-

-

-

-

At 31 March 2023

3,028

127

987

4,142

5

Stocks

2024
£

2023
£

Other inventories

-

930

6

Debtors

Current

2024
£

2023
£

Trade debtors

335

(110)

Other debtors

-

8

 

335

(102)

 

Electro Medical Services (Basingstoke) Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

7

Creditors

Creditors: amounts falling due within one year

2024
£

2023
£

Due within one year

Trade creditors

37

-

Taxation and social security

-

1,959

Accruals and deferred income

-

726

Other creditors

2,401

-

2,438

2,685

8

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Allotted, issues and fully paid of £250 each

2

500

2

500

       

9

Dividends

2024

2023

£

£

Final dividend of £Nil (2023 - £Nil) per ordinary share

-

-

Interim dividend of £Nil (2023 - £4,700.00) per ordinary share

-

4,500

-

4,500

 

 

10

Related party transactions

Director's remuneration

The director's remuneration for the year was as follows:

2024
£

2023
£

Remuneration

7,000

12,400